Skip to main content

Table 3 Follow-up outcomes

From: Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study

Variables AC group
(n = 67)
AT group
(n = 54)
p value
All-cause death 0 0
Ischemic events 3 (4.5%) 3 (5.6%)
 Myocardial infarction 2 (3.0%) 2 (3.7%)  
 Ischemic stroke 1 (1.5%) 0  
 Repeat revascularization 0 1 (1.9%)  
Bleeding events 2 (3.0%) 1 (1.9%)
 Cardiac tamponade 1 (1.5%) 0  
 Hemorrhagic stroke 0 1 (1.9%)  
 Gastrointestinal bleeding 1 (1.5%) 0  
MACCE 2 (3.0%) 3 (5.6%) 0.514
  1. AC aspirin plus clopidogrel, AT aspirin plus ticagrelor, MACCE major cardiac and cerebrovascular events, No. number, SD standard deviation